About Naslund Medical

placeholder

Naslund Medical AB is a privately held medical products company focused on the improved management and care of patients receiving radiation therapy. As the pioneer and leader in developing new technology for fiducial markers, Naslund Medical AB markets Gold Anchor worldwide. Gold Anchor enables quicker and more effective radiation therapy treatment with increased patient safety. Naslund Medical AB is based in Sweden with a subsidiary in the U.S. and contracted distributors on a global level.

Ingemar Näslund founder of Naslund Medical Owner and inventor
Ingemar Naslund, M.D, Ph.D. Associate professor in Oncology
ingemar.naslund@goldanchormarker.com

Background

The Gold Anchor has been invented and developed by Ingemar Naslund, M.D, Associate Professor, working as head of the Division of Radiation Theraphy, Radiumhemmet, Karolinska University Hospital, Stockholm, Sweden for 20 years, where he was one of the inventors of the SBRT technique in 1991 together with Ingmar Lax and Henric Blomgren.

Contact details

Naslund Medical AB
Vassvagen 21
14139 Huddinge, Sweden
Phone: +46 706 105 411
Fax: +46 850 900 381

Naslund Medical Inc.
150 N Michigan Ave, Suite 1950
Chicago, IL 60601, USA
Phone: (312) 212 3470
Fax: (312) 277 6688

Email: info@goldanchormarker.com

Quality Management System

Naslund Medical AB is certified to SS-EN ISO 13485:2016 and according to the Directive 93/42/EEC on Medical Devices, Annex II, Full Quality Assurance System.

Swecare Export Award 2019

Naslund Medical has been awarded 2019 year’s Swecare Export Award for its innovation power, strategy and strong exports. We are grateful, proud and happy to be part of improving cancer care throughout the world.

Link to press release (text in Swedish).

Exhibitions and Events

We look forward to meet with you at an upcoming event. Or maybe we already met some of your colleagues at these recent meetings?

Events 2019 onwards

PTCOG58, booth #16June 10-15Manchester, UKLink
ASTRO 61st Annual meeting, booth #1015September 15-18Chicago, IL, USALink
The RSS, The Radiosurgery SocietyApril 2-4, year 2020Washington, DC, USALink

Recent meetings

AUA, Americal Urological Association, booth #5011May 3-6Chicago, IL, USALink
ESTRO 38, booth #3440April 26-29Milan, ItalyLink
Finska Strålbehandlingsdagarna (Finnish Radiotherapy Days)March 28-29Kuopio, FinlandLink
Southwest Prostate Cancer SymposiumApril 11-14Scottsdale, AZ, USALink
NAPT, The National Proton ConferenceMarch 24-27Miami, FL, USALink
The RSS, The Radiosurgery SocietyMarch 21-23San Diego, CA, USALink
Genitourinary Cancers SymposiumFebruary 14-15, 2019San Francisco, CA, USALink
SABR ConsortiumNov 29-30, 2018Bristol, United KingdomLink
ISIT2018Nov 10-11, 2018Saga, JapanLink
ASTROOct 21-23, 2018San Antonio, TX, USALink
PTCOG 57May 23-25, 2018Cincinnati, Ohio, USALink
AUA, American Urological AssociationMay 18-21, 2018San Francisco, CL, USALink
ARS, American Radium Society, 100th Annual meetingMay 5-8, 2018Orlando, FL, USALink
ESTRO 37April 20-24, 2018Barcelona, SpainLink
NAPT, The National Proton ConferenceMarch 25-28, 2018Scottsdale, Arizona, USALink
2017 RSS Annual Scientific Meeting (the Radiosurgery Society)November 2-4, 2017Las Vegas, NV, USALink
PTCOG-NAOctober 23-25, 2017Chicago, IL, USALink
ASTROSeptember 24-26, 2017San Diego, CA, USALink
UKRCOJune 12-14, 2017Manchester, UKLink
PTCOG 56May 11-13, 2017Yokohama, Kanagawa, JapanLink
ARS 99th Annual Meeting (American Radium Society)May 6-9, 2017Colorado Springs, COLink
ESTRO 36May 5-8, 2017Vienna, AustriaLink
Sjuksköterskor i CancervårdApril 27-28, 2017Stockholm, SwedenLink
Finska Strålbehandlingsdagarna (Finnish Radiotherapy Days)April 6-7, 2017Helsinki, FinlandLink
Proton Therapy CongressMarch 29-30, 2017Amsterdam, the NetherlandsLink
NCoBC2017: The 27th Annual Interdisciplinary Breast Center ConferenceMarch 11-13, 2017Las Vegas, NV, USALink
NACP symposium (Nordic Association for Clinical Physics)February 6-8, 2017Oslo, NorwayLink
ASTRO’s 58th Annual MeetingSeptember 25-27, 2016Boston, MA, USALink
The SRS/SBRT Scientific Meeting 2016June 16-18, 2016Orlando, FL, USALink
ESTRO 35April 29-May 3, 2016Turin, Italy. Booth #1800Link
2016 Genitourinary Cancers SymposiumJanuary 7-9, 2016San Francisco, CA, USALink
JASTRO’s 28th Annual MeetingNovember 19-21, 2015Beisia Culture Hall, Maebashi, JapanLink
ASTRO’s 57th Annual MeetingOctober 18-21, 2015San Antonio, TX, USA. Booth #702Link

Partnership with academia & healthcare

Swedish Testbed for Innovative Radiotherapy

Naslund Medical is one of the partners in a consortium aiming at establishing a Swedish testbed for innovative radiotherapy. The testbed will allow healthcare and industry to test new technology and new methods in clinical settings – and jointly drive the development of cancer treatment with radiation therapy. Learn more >

gentletherapy

Gentle Radiotherapy

Since all cancer treatment have adverse effects on the patient, we have to do it right the first time for every individual patient, this increases the chance of cure without harming the patient – “Gentle therapy”.

Naslund Medical is one of the business partners in a consortium consisting of all teaching hospitals associated with academia and 7 important industrial companies. The long-term goal is to create a large-scale national world class platform for cancer treatment. Learn more >

gentle-radiotherapy

mail sign

Subscribe to our newsletter

Do you want to keep updated about Gold Anchor? Product development, exhibitions, testimonials. Sign up for our newsletter.

By clicking Subscribe, you agree to that you have read our Privacy Policy including Cookies.